drugset / Trial / NCT01134549

Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male Volunteers

NCT01134549

Phase 1 Completed 32 enrolled KAI Pharmaceuticals Nucleus Network Ltd · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to characterize the safety and tolerability of etelcalcetide in healthy young males.

Timeline

Start
2010-06-09
Primary completion
2010-07-31
Completion
2010-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Etelcalcetide Other / unclassified 0.5 mg Intravenous